Workflow
企业上市融资
icon
Search documents
芯碁微装:拟发行H股 并在香港联交所上市
Mei Ri Jing Ji Xin Wen· 2025-08-13 11:00
Core Viewpoint - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy, improve international brand image, and strengthen core competitiveness [2] Company Actions - The board of directors and the supervisory board have approved the relevant proposal for the H-share issuance [2] - The specific details of the issuance are yet to be determined [2] - The issuance will require approval from the shareholders' meeting and regulatory bodies including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2]
芯碁微装:拟发行H股并在香港联交所上市
Xin Lang Cai Jing· 2025-08-13 10:27
Core Viewpoint - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy, improve international brand image, and strengthen financing channels and core competitiveness [1] Group 1 - The board and supervisory committee have approved the relevant proposal, but specific details are yet to be determined [1] - The issuance will require approval from the shareholders' meeting and regulatory bodies such as the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1] - The company will disclose further developments in a timely manner due to significant uncertainties involved [1]
中微半导:拟发行H股股票并在香港联交所上市
news flash· 2025-07-22 11:05
Core Viewpoint - The company plans to issue overseas listed foreign shares (H-shares) and apply for listing on the main board of the Hong Kong Stock Exchange, aiming to enhance its global strategic layout and international brand image [1] Group 1 - The initiative is intended to diversify financing channels and further enhance core competitiveness [1] - Specific details regarding the issuance are not yet determined, and there is significant uncertainty regarding the approval, filing, and review processes [1]
辰欣药业股份有限公司_招股说明书(申报稿2014年5月6日报送)
2023-08-04 03:42
辰欣药业股份有限公司 CISEN PHARMACEUTICAL CO., LTD. (济宁高新区同济科技工业园) 首次公开发行股票招股说明书 (申报稿) 保荐机构(主承销商) (山东省济南市经七路 86 号) 辰欣药业股份有限公司招股说明书(申报稿) 辰欣药业股份有限公司招股说明书(申报稿) 发行价,或者上市后 6 个月期末收盘价低于发行价,持有公司 股票的锁定期限自动延长 6 个月;如遇除权、除息事项,上述 发行价作相应调整。 4、乾鼎投资、昆吾九鼎、东阳昊润、龙邦贸易、智仕九鼎、 宝寿九鼎、兴贤九鼎、盛世九鼎、卓兴九鼎及赵白雪等 21 名自 然人股东承诺:自公司股票上市之日起十二个月内不转让或者 委托他人管理其本次发行前已持有的发行人股份,也不由发行 人回购其持有的股份。 5、本次发行前间接持有公司股份的董事、监事或高级管理 人员韩延振、郝留山、卢秀莲、刘霁、张祥林、李峰、樊月玲、 张斌承诺:自公司股票上市之日起三十六个月内,不转让或者 委托他人管理其本次发行前间接持有的公司股份,也不由发行 人回购其间接持有的股份。间接所持股票在锁定期满后两年内 减持的,减持价格不低于发行价;公司上市后 6 个月内如公司 ...